T

T-NeuroPharma

10 employees

TNeuroPharma develops a therapeutic-based technology focusing on the T-cell contribution in tracking and treating neurodegenerative disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Therapeutics

Medical

Date founded

2018

Funding rounds raised

T

T-NeuroPharma raised undisclosed on May 18, 2021

Investors: Arrowhead Innovation Fund

FAQ